# APREPITANT
> **NDA218754** · New Drug Application · Sponsor: AZURITY · Approved 2024-07-25
## Drug
- **FDA Application Number:** NDA218754
- **Application type:** New Drug Application
- **Brand name:** APREPITANT
- **Generic name:** Aprepitant
- **Active ingredients:** APREPITANT
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AZURITY
- **First approval:** 2024-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218754)
---
*AI Analytics · CC0 1.0*